Clincosm LogoSign in Get a demo

Obesity

Showing NaN - NaN of 55
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Obesity Trial in United States (Cagrilintide, Semaglutide, Tirzepatide)

Not yet recruiting
  • Obesity
  • Birmingham, Alabama
  • +44 more
Nov 9, 2023

Obesity, Cardiovascular Diseases Trial in Worldwide (Retatrutide, Placebo)

Not yet recruiting
  • Obesity
  • Cardiovascular Diseases
  • Phoenix, Arizona
  • +165 more
May 22, 2023

Obesity, Overweight, Type 2 Diabetes Trial in Worldwide (Orforglipron, Placebo)

Not yet recruiting
  • Obesity
  • +2 more
  • Pelham, Alabama
  • +135 more
May 15, 2023

Type 2 Diabetes, Obesity, Overweight or Obesity Trial in Worldwide (Orforglipron, Insulin Glargine)

Recruiting
  • Type 2 Diabetes
  • +5 more
  • Muscle Shoals, Alabama
  • +320 more
Apr 12, 2023

Obesity, Obese, Overweight or Obesity Trial in New Zealand (biological, drug, other)

Recruiting
  • Obesity
  • +2 more
  • Bimagrumab
  • +2 more
  • Anniston, Alabama
  • +23 more
Feb 1, 2023

Obesity Trial in United States (Semaglutide 2.4 mg and NNC0165-1875 2.0 mg, Semaglutide 2.4 mg and 2.0 mg, Semaglutide 2.4 mg

Completed
  • Obesity
  • Semaglutide 2.4 mg and NNC0165-1875 2.0 mg
  • +3 more
  • Walnut Creek, California
  • +13 more
Jan 23, 2023

Overweight, Obesity and Diabetes, Type 2 Trial (Cagrilintide, Semaglutide, Placebo cagrilintide)

Not yet recruiting
  • Overweight
  • +2 more
  • Concord, California
  • +147 more
Jan 24, 2023

Obesity, Diabetes, Type 2 Trial in Worldwide (Semaglutide, Placebo)

Recruiting
  • Obesity
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +73 more
Jan 24, 2023

Obesity Trial in Worldwide (Semaglutide, Placebo)

Recruiting
  • Obesity
  • Birmingham, Alabama
  • +106 more
Jan 24, 2023

Obesity Trial in Worldwide (semaglutide 2.4 mg, semaglutide 2.4 mg ())

Active, not recruiting
  • Obesity
  • semaglutide 2.4 mg
  • semaglutide 2.4 mg (placebo)
  • Montgomery, Alabama
  • +64 more
Jan 24, 2023

Diabetes, Obesity Trial in Worldwide (PF-07081532, Placebo, Rybelsus)

Recruiting
  • Diabetes Mellitus
  • Obesity
  • Centreville, Alabama
  • +55 more
Jan 18, 2023

Obesity, Overweight Trial in Worldwide (Tirzepatide, Placebo)

Recruiting
  • Obesity
  • Overweight
  • Gilbert, Arizona
  • +695 more
Jan 18, 2023

Overweight, Obesity Trial in Worldwide (Semaglutide, Placebo (semaglutide))

Active, not recruiting
  • Overweight
  • Obesity
  • Birmingham, Alabama
  • +804 more
Dec 19, 2022

Diabetes, Obesity Trial in United States (PF-06882961, Placebo)

Completed
Has Results
  • Diabetes
  • Obesity
  • Phoenix, Arizona
  • +37 more
Nov 8, 2022

Obesity, Nonalcoholic Fatty Liver Disease, Cardiovascular Disease Trial in Jacksonville (N-acetyl cysteine 600 mg once/day,

Completed
  • Obesity
  • +2 more
  • N-acetyl cysteine 600 mg once/day
  • +2 more
  • Jacksonville, Florida
    Nemours Children's Clinic/Alfred I duPont Hospital
Oct 13, 2022

Overweight, Obesity Trial in Worldwide (Gelesis100, )

Completed
Has Results
  • Overweight
  • Obesity
  • Gelesis100
  • placebo
  • Anaheim, California
  • +35 more
Aug 8, 2022

Obesity, Adiposity Trial in Scottsdale, Jacksonville, Rochester (Hybrid Argon Plasma Coagulation (HAPC))

Not yet recruiting
  • Obesity
  • Adiposity
  • Hybrid Argon Plasma Coagulation (HAPC)
  • Scottsdale, Arizona
  • +2 more
Aug 3, 2022

Obesity Trial in Worldwide (Semaglutide, Placebo (semaglutide))

Active, not recruiting
  • Obesity
  • Fairhope, Alabama
  • +97 more
Jun 15, 2022

Obesity, Overweight Trial in Puerto Rico, United States (LY3437943, Placebo)

Active, not recruiting
  • Obesity
  • Overweight
  • Scottsdale, Arizona
  • +27 more
May 10, 2022

Overweight, Obesity Trial in United States (Semaglutide, Placebo (semaglutide), Liraglutide)

Completed
Has Results
  • Overweight
  • Obesity
  • Birmingham, Alabama
  • +18 more
Apr 26, 2022

Insulin Resistance, Obesity Trial in Scottsdale, Jacksonville, Rochester (Resistance Exercise)

Recruiting
  • Insulin Resistance
  • Obesity
  • Resistance Exercise
  • Scottsdale, Arizona
  • +2 more
Apr 11, 2022

Overweight, Obesity Trial in Worldwide (Semaglutide, Placebo (Semaglutide))

Completed
Has Results
  • Overweight
  • Obesity
  • Birmingham, Alabama
  • +40 more
Mar 21, 2022

Overweight, Obesity Trial in Worldwide (NNC0174-0833, Placebo (NNC0174-0833), Liraglutide 3.0 mg)

Completed
  • Overweight
  • Obesity
  • Anaheim, California
  • +53 more
Feb 24, 2022

Overweight, Obesity Trial in United States

Recruiting
  • Overweight
  • Obesity
    • Little Rock, Arkansas
    • +27 more
    Feb 11, 2022

    Older Population That is Overweight or Obese

    Completed
    • Obesity
    • Aging
    • Short Performance Physical Battery (SPPB Test)
    • +2 more
    • Jacksonville, Florida
    • +1 more
    Dec 13, 2021